TRANSCODE THERAPEUTICS, INC. Shareholders' Equity
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Shareholders' Equity of -$27.69 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$27.69M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.25M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $10.34M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.43M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$27.69M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $10.34M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.43M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $6.15M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $10.29M 10-Q · filed 2026-08-14 |
| 2024-12-31 | -$2.02M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $1.32M 10-Q · filed 2025-11-14 |
| 2024-03-31 | $4.58M 10-Q · filed 2025-11-14 |
| 2023-12-31 | $1.64M 10-K · filed 2026-04-15 |
| 2023-09-30 | $4.44M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $2.09M 10-Q · filed 2024-11-14 |
| 2023-03-31 | -$236.79K 10-Q · filed 2024-11-14 |
| 2022-12-31 | $3.24M 10-K · filed 2025-04-15 |
| 2022-09-30 | $8.24M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $12.43M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $17.00M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $20.40M 10-K · filed 2024-04-01 |
| 2021-09-30 | $23.16M 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$5.04M 10-Q · filed 2022-11-14 |
| 2021-03-31 | -$7.85M 10-Q · filed 2022-11-14 |
| 2020-12-31 | -$3.41M 10-K · filed 2023-03-31 |
| 2020-09-30 | -$2.62M 10-Q · filed 2021-11-15 |
| 2020-06-30 | -$1.28M 10-Q · filed 2021-11-15 |
| 2020-03-31 | -$1.15M 10-Q · filed 2021-11-15 |
| 2019-12-31 | -$1.11M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |